Delivery Order SPE2DB25D3504-SPE2DB25FVVPF

Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,615.87, is for the delivery of the medication Loestrin 21 1.5-30 Tablet 21s. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that will run through April 2024. Amerisourcebergen holds a separate $999,999,999 IDC with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $3,115.38 to provide Loestrin 21 1-20 tablets. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a variety of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $2,181.80, is for the delivery of Loestrin 21 1-20 tablets and is a firm fixed-price Delivery Order with no set-aside designation. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,565.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,014,706 units of the prescription medication Loestrin 21 1-20 Tablet in 21-count packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. This award is not a set-aside contract, indicating open...
This federal contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) is a delivery order valued at $1,530.34 for the supply of Loestrin 21 1-20 tablets. The contract has an ultimate completion date of April 27, 2023 and was awarded on April 26, 2023. It is a firm fixed-price contract with no set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for Loestrin 21 1-20 tablet 21s, a pharmaceutical product, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.93 delivery order contract is a firm fixed-price award from the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.44 firm fixed-price delivery order covers the supply of Loestrin 21 1-20 tablet medication to support military and federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVEGF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,186.12 delivery order contract is for the supply of 4,567,935,805 units of the prescription medication Loestrin 21 1-20 tablet 21s. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,636.35 firm fixed-price delivery order is for the supply of Loestrin 21 1.5-30 tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $4,331.04 firm fixed price delivery order is for the supply of Loestrin 21 1-20 tablet medication. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVVPF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.70 delivery order contract is for the supply of the medication Loestrin 21 1-20 tablet 21s, a fixed-price arrangement without any set-aside designation.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts, potentially involving at least three different contractors, which may provide additional opportunities for Amerisourcebergen Drug Corp to serve government healthcare customers.

Generated 10/15/25, 9:56 AM